John H. Heiligenstein

Fluoxetine for Acute Treatment of Depression in Children and Adolescents: A Placebo-Controlled, Randomized Clinical Trial

Graham J. Emslie, John H. Heiligenstein, Karen Dineen Wagner et al. · Journal of the American Academy of Child & Adolescent Psychiatry · 2002 · 574 citations

Acute Treatment, Randomized Clinical Trial, Psychiatry +12

Results From 2 Proof-of-Concept, Placebo-Controlled Studies of Atomoxetine in Children With Attention-Deficit/Hyperactivity Disorder

Thomas Spencer, John H. Heiligenstein, Joseph Biederman et al. · The Journal of Clinical Psychiatry · 2002 · 336 citations

Fluoxetine Treatment for Obsessive-Compulsive Disorder in Children and Adolescents: A Placebo-Controlled Clinical Trial

Daniel Geller, S. Hoog, John H. Heiligenstein et al. · Journal of the American Academy of Child & Adolescent Psychiatry · 2001 · 321 citations

Psychiatry, Medicine, Psychotropic Medication +12

Atomoxetine and Methylphenidate Treatment in Children With ADHD: A Prospective, Randomized, Open-Label Trial

Christopher J. Kratochvil, John H. Heiligenstein, Thomas Spencer et al. · Journal of the American Academy of Child & Adolescent Psychiatry · 2002 · 294 citations

Open-label Trial, Adhd, Psychiatry +10

Recovery from depression, work productivity, and health care costs among primary care patients

Dennis A. Revicki, John H. Heiligenstein, Louis C. Grothaus et al. · General Hospital Psychiatry · 2000 · 268 citations

Family Medicine, Primary Care, Health Economics +12